Cigarette smoking and erectile dysfunction : focus on NO bioavailability and ROS generation.

Simple item page
dc.contributor.authorTostes, Rita de Cassia Aleixo
dc.contributor.authorCarneiro, Fernando Silva
dc.contributor.authorLee, Anthony
dc.contributor.authorGiachini, Fernanda Regina Casagrande
dc.contributor.authorLeite, Romulo
dc.contributor.authorOsawa, Yoichi
dc.contributor.authorWebb, Robert Clinton
dc.date.accessioned2017-03-24T17:36:23Z
dc.date.available2017-03-24T17:36:23Z
dc.date.issued2008
dc.description.abstractIntroduction—Thirty million men in the United States suffer from erectile dysfunction (ED) and this number is expected to double by 2025. Considered a major public health problem, which seriously affects the quality of life of patients and their partners, ED becomes increasingly prevalent with age and chronic smoking is a major risk factor in the development of ED. Aim—To review available evidence concerning the effects of cigarette smoking on vascular changes associated with decreased nitric oxide (NO) bioavailability and increased reactive oxygen species (ROS) generation.Methods—We examined epidemiological and clinical data linking cigarette smoking and ED, and the effects of smoking on vascular NO bioavailability and ROS generation. Main Outcome Measures—There are strong parallels between smoking and ED and considerable evidence supporting the concept that smoking-related ED is associated with reduced bioavailability of NO because of increased ROS. Results—Cigarette smoking-induced ED in human and animal models is associated with impaired arterial flow to the penis or acute vasospasm of the penile arteries. Long-term smoking produces detrimental effects on the vascular endothelium and peripheral nerves and also causes ultrastructural damage to the corporal tissue, all considered to play a role in chronic smokinginduced ED. Clinical and basic science studies provide strong indirect evidence that smoking may affect penile erection by the impairment of endothelium-dependent smooth muscle relaxation or more specifically by affecting NO production via increased ROS generation. Whether nicotine or other products of cigarette smoke mediate all effects related to vascular damage is still unknown. Conclusions—Smoking prevention represents an important approach for reducing the risk of ED. The characterization of the components of cigarette smoke leading to ED and the mechanisms by which these components alter signaling pathways activated in erectile responses are necessary for a complete comprehension of cigarette smoking-associated ED.pt_BR
dc.identifier.citationTOSTES, R. de. C. A. et al. Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. The Journal of Sexual Medicine, v. 5, p. 1284-1295, 2008. Disponível em: <http://www.sciencedirect.com/science/article/pii/S1743609515320634>. Acesso em: 10 jan. 2017.pt_BR
dc.identifier.doihttps://doi.org/10.1111/j.1743-6109.2008.00804.x
dc.identifier.issn 1743-6095
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/7464
dc.identifier.uri2http://www.sciencedirect.com/science/article/pii/S1743609515320634pt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectPassive smokingpt_BR
dc.subjectNitric Oxidept_BR
dc.subjectReactive Oxygen Speciespt_BR
dc.titleCigarette smoking and erectile dysfunction : focus on NO bioavailability and ROS generation.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Collections
DEFAR - Artigos publicados em periódicos